Source: Techstartups

Distributed Bio: 'Pandemic' series scientist, Dr. Jacob Glanville, is developing antibody therapy drug to treat coronavirus (COVID-19) patients

As coronavirus pandemic claimed over 10,000 lives around the world, the race is on for the development of coronavirus vaccine. However, experts say it may take between 12 to 24 months before the vaccine becomes available. Some are going as [...]The post 'Pandemic' series scientist, Dr. Jacob Glanville, is developing antibody therapy drug to treat coronavirus (COVID-19) patients appeared first on Tech News | Startups News.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jacob Glanville's photo - Chairman & CEO of Distributed Bio

Chairman & CEO

Jacob Glanville

CEO Approval Rating

90/100

Read more